Skip to content

Inflation Reduction Act 

Changes to Medicare Prescription Benefits

Inflation Reduction Act  for Medicare Prescription Drug (Part D) coverage.

The new guidelines for Part D coverage will be implemented from 2022 to 2026. 

2025:
    • Maximum out of pocket implemented
      • Medicare Beneficiaries with Part D Plans cannot pay more than $2,000 in out of pocket costs for medications.
      • The cap may be adjusted each year for inflation.
    • Medicare Prescription Payment Plan implemented
2024-2026:
    • Part D premium increase cap of 6%/year
2022- 2024:
    • Inflation protected medication costs
      • As of 10/01/2022 pharmaceutical manufacturers must pay a penalty if the cost of a medication increases faster than inflation over a 12 month period
    • Coverage for Shingles Vaccine at no cost
      • All adult vaccines recommended by the Centers for Disease Control and Prevention will be covered by Part D Plans without imposing Plan deductibles or cost sharing.
      • Also includes Varicella (chicken pox),Hepatitis A, Hepatitis B, Meningococcal B vaccines
      • The following vaccines are currently covered under Medicare Part B and therefore are not impacted by the new legislation: Influenza, COVID, and Pneumococcal/Pneumonia
    • Injectable Insulin’s = $35/month and not subject to the Plan’s deductible.
      • Included = Injectable insulins (either vial or pen) which are included in a Plan’s Part D Formulary (list of covered medications)
      • Not included = Oral diabetic meds or injectable A1C meds.
    • Removal of 5% co-insurance during catastrophic phase
  •  

Inflation Reduction Act Summary 3m 1s

Federal Government can negotiate costs for medications

1st Medications for Negotiation

Contact Us

Our Address

100 Campbell Blvd.
Suite 100
Exton, PA 19341

Contact Us

Info@HTA-insurance.com
P: 610.430.6650
F: 610.430.6652

© Copyright HTA | Privacy Policy | Designed by Apis Productions